Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor + G-CSF + chemotherapy mobilization for tandem autologous transplantation in relapsed or refractory DLBCL
2010-024446-30Phase 2Active
- Sponsor
- Azienda Ospedaliera Cardinale G. Panico
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in diffuse large B-cell lymphoma (DLBCL), sponsored by Azienda Ospedaliera Cardinale G. Panico. Started Jun 2012; status: active.
02
Drugs
plerixafor
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on 2010-024446-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024446-30.